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1     INTRODUCTION 
Reform schools (RS) in Finland are foster care institutions where children and adolescents are 
placed when other child welfare services fail to provide adequate education and care. This study is a 
part of After reform school study (ARSS), project by the Finnish Institute for Health and Welfare 
(Terveyden ja hyvinvoinnin laitos, THL), the aim of which is to research adolescent’s life after RS 
placement. The aim of this study is to investigate how much those placed in RS participate in 
rehabilitation services provided by the Social Insurance Institution of Finland (Kela) and purchase 
psychopharmacons after RS placement, compared to their peers. The results of this study help to 
develop mental health care in RS and aftercare, and also in the public health services in general. 
 
1.1    REFORM SCHOOLS AND OUT-OF-HOME CARE 
1.1.1   REFORM SCHOOLS IN FINLAND 
There are seven RS in Finland: five state-owned and two private. Reasons for RS placement are 
usually manifold, including serious behavioral problems, alcohol and drug abuse, criminality or 
problems with school attendance (Kitinoja, 2005; Pekkarinen, 2017). The aim of RS placement is to 
provide structural, needs based care and help adolescents to graduate from compulsory school and 
offer an opportunity to establish secure relationships, strengthen protective factors and receive 
support in transitional phases (Finnish Institute for Health and Welfare, 2013). RS provides also 
some mental health services like appointments with psychologist and group rehabilitation (e.g. 
Aggression Replacement Training, ART). If needed, services like psychotherapy or 
neuropsychological rehabilitation are provided by public special health care. In 2018 there were 
18544 minors placed outside home (Kuoppala, Forsell, & Säkkinen, 2019); 250-300 of them were 
placed in reform schools. Taken together, RS enable involvement in education, daily routines and 
health services for adolescents who have very high risk for adverse outcomes.  
 
1.1.2   ADULT AGE PROBLEMS AMONG OUT-OF-HOME CARE POPULATION  
Internationally, there is a large number of studies on adolescents placed in out-of-home care 
(OOHC). According to them many adolescents transitioning from foster care have problems on 
different life domains. A systematic review shows that former OOHC adolescents have more 
mental health problems and substance abuse, problems with achieving a high school and post-
secondary school degree and difficulties with employment stability and income compared to 
general population peers (Gypen, Vanderfaeillie, De Maeyer, Belenger, & Van Holen, 2017).  
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These results are consistent with the results of another systematic review conducted in the Nordic 
countries (Kääriälä & Hiilamo, 2017) which show that OOHC history is associated with problems 
with educational achievements, income and overall employment, teenage parenthood, criminality, 
suicide risk, and an excess of mental health problems especially if placed in adolescence. There are 
also some specific results worth noticing. According to cohort studies conducted in the Nordic 
countries, after leaving care, those placed in OOHC during childhood need more mental health 
services in adulthood compared to their peers (Kääriälä, Berlin, Lausten, Hiilamo, & Ristikari, 
2018). Problems with social life and health (Brännström, Forsman, Vinnerljung, & Almquist, 2017) 
along with education and employment (Vinnerljung, Forsman, Bra, & Almquist, 2017) are present 
also in midlife. In addition, problems are prone to transfer from one generation to the next: children 
of former OOHC adolescents are at greater risk to OOHC placement (Wall-Wieler, Almquist, Liu, 
Vinnerljung, & Hjern, 2018). 
 
1.1.3   REFORM SCHOOL RESEARCH IN FINLAND 
The results of Finnish RS studies are parallel with the international OOHC studies. A growing body 
of research shows that psychiatric morbidity among the adolescents placed in the RS is high in 
Finland. Almost 90% of adolescents living in a RS have some mental disorder, the most common 
ones being conduct disorder (76%), affective syndrome (50%) and substance abuse (40%), based on 
a study conducted in one RS (Lehto-Salo, 2011). Another research project conducted in another RS 
confirmed that adolescents placed to RS have substantionally more psychiatric symptoms than their 
peers (Manninen et al., 2010). Also problems in naming and processing feelings, and recognizing 
one´s own symptoms of depression is typical (Manninen et al., 2011). In a five-year follow-up 
study those placed to RS manifested more psychoses than their peers (Manninen et al., 2014). The 
risk for later schizophrenia is eight-fold, and schizophrenia also manifests earlier than among 
general population peers (Manninen, Latvala, Torniainen-Holm, Suvisaari, & Lindgren, 2018). In 
general, the prevalence of psychiatric morbidity seems to be growing. According to a quantitative 
study comparing two cohorts (children placed in RS in 1996 and 2000) and their placement history, 
in total the cohort 2000 had more problems than the cohort 1996 (Kitinoja, 2005). 
 
Neuropsychological problems are also common among those placed in RS. Adolescents placed in 
RS have problems with cognition, especially with verbal tasks (Manninen et al., 2013). The 
weakness of verbal skills, and problems with executive functions are typical (Lehto-Salo, 2011).  
There are some gender-related issues worth noticing. Especially among girls the comorbidity of 
mental disorders has been found to be high (Lehto-Salo, 2011) Among boys the symptoms of 
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depression tend to be hidden under externalizing symptoms and thus their depression is often 
underdiagnosed and insufficiently treated (Manninen et al., 2010). 
 
The problems tend to continue in adulthood, after RS placement ends. The results of the ARSS 
indicate that the overall risk for criminality after reform school placement is very high and 
especially men are prone to commit crimes (66% of all; 78% of men compared to 41% of women) 
(Manninen, Suvisaari, Marola, & Aaltonen, 2017). These results are consistent with an earlier 
small-scale study which showed that in particular boys have later criminality and about half of them 
commit a violent offence (Manninen et al., 2013). The results of the ARSS indicate also that the 
risk for premature death is higher among adolescents leaving RS and the most common causes of 
death are mental health problems or substance-related problems  (Manninen, Pankakoski, Gissler, & 
Suvisaari, 2015). Further, former RS placed women tend to have more challenges with their 
reproductive health (Lehti, Gissler, Suvisaari, & Manninen, 2015). Those placed in RS are also at 
greater risk to have only compulsory school education, and the association between substance 
related disorders and education is negative (Talaslampi, Jahnukainen, & Manninen, 2019).  
 
Although the risks for many problems after RS placement are high, the life courses of former RS 
adolescents vary. In a qualitative study researchers discovered three pathways after leaving reform 
school: one group copes very well in their lives, another group has some problems but is able to 
handle them, and another group has severe problems to integrate into society (Jahnukainen, 2007).  
In another qualitative study researchers studied different types of agencies leading to good 
adulthood after RS placement, and found that even those with an opposing agency were able to 
adapt to social rules and reach mature self-regulation after leaving RS (Niiranen, Lämsä, Kiviruusu, 
& Manninen, under review).   
 
Taken together, adolescents placed in RS have an explicit need for multi-professional support due 
to the severity and the variety of their problems. Mental health problems are very common among 
adolescents in reform schools. After leaving RS the problems of these adolescents seem to continue 
and in the lives of some of them they culminate causing lifelong suffering.  
 
1.1.4   AFTERCARE AND MENTAL HEALTH SERVICES AFTER LEAVING CARE 
Transition from adolescence to adulthood is a complex nonlinear phase where adolescents reach 
autonomy but need often still support and advice from their families and community (Lindell & 
Campione-Barr, 2017). For former OOHC adolescents, this transition is even more demanding than 
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for youth in general population. Their transition has been described as “accelerated” (Stein, 2008) 
because their families are often troubled, their personal relationships with peers may be destructive 
and once they leave care they are not able to return there, therefore they have to cope with 
independent adulthood on their own. Further, after leaving care living with low-resourced parents, 
who are incapable to support adolescents’ independence, has been discovered to have a possible 
negative impact on later education and employment (Fowler, Toro, & Miles, 2011; Miller, Paschall, 
& Azar, 2017).  
 
Even though there may be some mental health interventions provided by the foster care system 
(Hambrick, Oppenheim-Weller, N’zi, & Taussig, 2016), those leaving care have often negative 
attitudes towards mental health services (Miller et al., 2017). Therefore, after leaving care many 
adolescents drop their psychotropic medication and mental health services (Kang-Yi & Adams, 
2017). According to a research by McMillen and Raghavan (2009), specific reasons for former 
OOHC adolescents to drop psychotropic medication and mental health services are, that they do not 
like them, they feel that they do not need them and it is for the first time their own option to choose.  
 
Internationally, there are many transitional programs for adolescents leaving care to improve their 
overall situation (Heerde, Hemphill, & Scholes-Balog, 2018; Kang-Yi & Adams, 2017), but they do 
not always help adolescents to receive necessary mental health services (Lemon, Hines, & 
Merdinger, 2005). Only a small part of former OOHC adolescents feel that they have been “very 
prepared” to live on their own, whereas many of them wishes that they would have received more 
training and assistance after leaving care (Courtney, Lee, & Perez, 2011). Staying in care longer has 
been found to have an positive impact on receiving psychological or emotional couselling 
(Courtney M. & Dworsky A., 2006). In general, adolescents leaving care do not benefit from 
mentoring, if their placement has been unstable, and placement stability is the most important factor 
related to better education, and later, better education is linked to higher odds of employment 
(Cassarino-Perez, Crous, Goemans, Montserrat, & Sarriera, 2018). Taken together, those having 
stable lives in care and stable relationships with caregivers and enough time to prepare for 
independent living have better odds to manage their lives after leaving care. 
 
In Finland, after the OOHC placement ends at the age of consent - 18 years in Finland - the 
adolescent´s home municipality has the responsibility to provide aftercare for five years or until the 
adolescent turns 25 (Child Welfare Act 13.4.2007/417 § 75). Until 2020 the age limit was 21 years. 
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The purpose of aftercare is to support adolescents transition to self-supporting adult life; namely to 
find a residence, to study, to find a job and social attainment. 
 
1.2    REHABILITATION SERVICES PROVIDED BY THE SOCIAL INSURANCE 
INSTITUTION OF FINLAND 
According to Current Care Guidelines, adolescents’ and adults’ mental health problems are treated 
with psychotherapies, psychotropic medication or with combined treatment (e.g. Current Care 
Guidelines: Anxiety Disorders, 2019). Comparing the efficacy of psychotherapies and 
psychotrophic medication is challenging, for there are several methodological differences between 
the trials (Huhn et al., 2014). In general, combined treatment has been found to be superior to 
different therapies or psychotropic medication alone (Cuijpers et al., 2013; Huhn et al., 2014).  
 
Public rehabilitation services in Finland are provided by the Social Insurance Institution of Finland 
(Kela), health centers, hospitals and other public health and social service providers. Kela is an 
independent institution which works under the Finnish Parliament and provides social security 
benefits for all Finnish citizens. Kela’s rehabilitation services are regulated by the act (566/2005)  
of Finnish Parliament concerning the rehabilitation services and allowances provided by Kela, and 
are divided into vocational rehabilitation, intensive medical rehabilitation, rehabilitative 
psychotherapy, and rehabilitation services provided on a discretionary basis. The aim of vocational 
rehabilitation is to support or improve ability to work or to prevent incapacity to work and it can 
encompass for example training try-outs, vocational rehabilitation courses, and basic and advanced 
education and retraining. Intensive medical rehabilitation is aimed at people under 65 years old who 
need rehabilitation to manage their work, studying or other activities if they have a disease or 
disability impairing their daily living. Rehabilitative psychotherapy is aimed at people between 16 
and 67 years to support or improve their ability to work or study. (The Act Concerning the 
Rehabilitation Services and Allowances Provided by Kela 2005/566) 
 
The mental health rehabilitation service system of Kela is complex. Psychotherapy, 
neuropsychological rehabilitation and music therapy can be provided under the intensive medical 
therapy (Kela, 2020c). Alternatively, psychotherapy and music therapy can also be provided under 
the rehabilitative psychotherapy (Kela, 2020b). If the need for neuropsychological rehabilitation 
does not meet the requirements for intensive medical therapy it can also be provided on a 
discretionary basis (Kela, 2020a). Kela’s rehabilitation is usually free of charge but for example the 
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price of rehabilitative psychotherapy or neuropsychological rehabilitation can exceed the maximum 
compensation Kela offers (Kela, 2019a, 2020e). 
 
Kela provides also support for medication. The basic compensation is 40% of the price of 
medication (Kela, 2017). Among mental disorders an exception are serious psychoses and other 
serious mental disorders. In respect of them the amount of compensation is 100%. 
The participation in Kela’s medical rehabilitation, rehabilitative psychotherapy and vocational 
rehabilitation services has increased remarkably among all under 30-year-old Finns during the 
2010´s. Only the amount of the multidisciplinary individual rehabilitation has decreased in the same 
time period. Among 16-19-year-olds the vocational rehabilitation and among 20-29-year-olds the 
rehabilitative psychotherapy have been the most supported forms of rehabilitation. Women 
participate in Kela’s rehabilitation services more than men. (Gissler & Forsell, 2018). 
 
1.3    SUMMARY 
In summary, a growing body of research conducted among adolescents placed in RS show that the 
problems of these adolescents are multiple and severe, and they continue often to adulthood. 
Former OOHC adolescents participate in mental health services more than their peers (e.g. Kääriälä 
et al., 2018; Kestilä, Väisänen, Paananen, Heino, & Gissler, 2012), but there is no research on 
former RS adolescents’ participate in rehabilitation services and purchase psychopharmacons. As 
the need for adult age mental health care is evident, it is important to know how well the public 
mental health services meet their needs. Further, it is of interest to study possible  changes over 
years on both amount and type of services used. This information is important for the development 
of the accessibility of mental health services provided by the public health sector in general, and 
especially for developing care provided by RS and aftercare. 
 
2     AIMS OF THE STUDY 
The aim of this study is to answer the following questions: 
1. Do the persons placed in RS in their adolescence differ from their peers by the usage of 
rehabilitation services and the purchases of psychopharmacons? 
2. Is there gender differences in the usage of rehabilitation services and the purchases of 
psychopharmacons, within the persons placed in RS and their peers together? 
3. Are there any changes over the years in the usage of rehabilitation services and the 
purchases of  psychopharmacons, within the persons placed in RS and their peers together? 
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4. Do the persons placed in RS and their peers differ in the gender differences or changes over 
years in the usage of rehabilitation services or the purchases of psychopharmacons? 
 
 
3     METHODS 
3.1    SUBJECTS 
The subjects (N= 1074, 697 males and 377 females) were chosen from Finland's National Child 
Welfare Register (Kansallinen lastensuojelurekisteri) based on the entry “residing in a reform 
school” on 31st of December of 1991, 1996, 2001, 2006, or 2011 (Figure 1). The subjects with 
entries in more than one cohort were removed from the later one, and thus five cohorts were 
formed. A general population comparison group (N = 5313, 3444 males and 1869 females), 
matched by age, gender and the place of birth was obtained from the Population Register Centre, 
Finland. The aim was to have five matched comparison subjects for every RS subject. For 1017 RS 
subjects this succeeded, but for 57 (5.3%) RS cases only four matched comparison youth were 
located, as the proband had been born in a small municipality. All RS children were included in the 
study, regardless of the final number of controls. The data was acquired in the end of 2014. The 
study protocol was reviewed and approved by the institutional review board of the Finnish Institute 
for Health and Welfare.  
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Figure 1. Overview of the subjects. 
  8 
3.2    OUTCOME VARIABLES  
The outcome variables used in this study were the lengths of the psychotherapies in days and the 
amounts of purchases of psychopharmacons. The rehabilitation data was obtained from the 
Rehabilitation and Therapy Registry, kept by Kela. Psychotherapy variable included psychotherapy 
as intensive medical therapy, before year 2011 psychotherapy as rehabilitation services provided on 
a discretionary basis, and since year 2011 psychotherapy as rehabilitative psychotherapy. The 
original aim of this study was to investigate the participation in psychotherapy, music therapy and 
neuropsychological rehabilitation, but the participation in music therapy (0.4%) and 
neuropsychological rehabilitation (0.1%) was so minimal within the RS population and the control 
group that they were omitted from the analyses. 
 
The data of the purchases of psychopharmacons was obtained from the Prescription Drug Registry, 
kept also by Kela. Based on established quidelines, psychopharmacons were divided into 12 
subgroups: antiepileptics, Clonazepam independently, antipsychotics, Lithium independently, 
anxiolytics, Buspirone independently, drugs used for sleep disorders, antidepressants, 
psychostimulants used for ADHD, drugs used in nicotine dependence, drugs used in alcohol 
dependence, and drugs used in opioid dependence. The ATC-codes of these subgroups are compiled 
in Appendix A. 
 
There were zero purchases of antiepileptics, Clonazepam, drugs used in nicotine dependence and  
drugs used in opioid dependence, therefore they were left out from the analyses. Also there were 
only a few purchases of Lithium (at least one purchase: 0.3%) and Buspirone (at least one purchase: 
0.6%), therefore they were also omitted from the analyses. 
 
3.4    STATISTICAL ANALYSES 
The data was anonymized by the Finnish Institute for Health and Welfare before being provided to 
the researchers. Analyses were conducted using IBM SPSS Statistics version 25. In the final 
analyses, RS placement, cohort and gender were independent variables. Dependent variables were 
psychotherapy and the purchases of antipsychotics, anxiolytics, drugs used for sleep disorders, 
antidepressants, psychostimulants used for ADHD and drugs used in alcohol dependence. The cases 
of each dependent variable were categorized into two groups: has or has not participated in 
psychotherapy, or has or has not purchased psychopharmacons. Each dependent variable was 
analyzed separately. Analyses were conducted using  logistic regression with 1 000 bootstrapped 
samples, for the proportion of those who had participated in psychotherapy or purchased 
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psychopharmacons was small. Each independent variable and the interactions between RS 
placement and gender, and RS placement and cohort were controlled in the models. The best fitting 
models were chosen based on the upper limit of the confidence interval of each odds ratio before 
bootstrapping. If the limit was too high, the model was rejected and the predictor with the highest p-
value was left out from the next model. If either interaction in the final model was statistically 
significant, new logistic regressions were conducted for the RS group and control group separately. 
Relative risks in each model for every independent variable were calculated using marginal 
propabilities. 
 
The preliminary graphical observation and cross-tabulation revealed that the distributions of the 
dependent variables were zero-inflated and therefore further analyses of the exact lengths of the 
psychotherapy in days and the amounts of purchases of psychopharmacons with Poisson regression 
were not statistically valid. The descriptive statistics of the length of the psychotherapy in days and 
the amounts of purchases of psychopharmacons were cross-tabulated. 
 
 
4     RESULTS 
4.1    PSYCHOTHERAPY 
There was no significant difference between the subjects with RS background and the subjects in 
control group in participating in psychotherapy (Table 1). When both groups were pooled together, 
women participated in psychotherapy significantly (p<.001) more than men. Further, when both 
groups were pooled together, the cohort 2011 participated in psychotherapy significantly (p<.001) 
more than the reference cohort 1991. Other cohorts did not differ significantly from the reference 
cohort.  
 
The interaction of RS placement and gender was non-significant (Table 1). There was statistically 
significant (p<.01) difference between the RS and control groups between the different cohorts in 
the participation in psychotherapy. In the RS group those in the cohort 2001 participated more in 
psychotherapy than those in the  reference cohort 1991 (p<.05, Table 2). In the control group only 
those in the cohort 2011 attended psychotherapy less than those in the reference cohort 1991 
(p<.001). Other cohort differences were not statistically significant. The five-number summaries for 
the lengths of psychotherapies are compiled in Appendix B. 
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4.2    PSYCHOPHARMACONS 
The subjects with RS background purchased all types of psychopharmacons more than the subjects 
in the control group, and all of the differences were significant (p<.001, Table 1). There were some 
differences between the purchases of different psychopharmacons. All of the results are described 
in detail in the following subchapters. 
 
4.2.1   ANTIPSYCHOTICS 
The subjects with RS background purchased antipsychotics significantly (p <.001) more than the 
subjects in the control group (Table 1). When both groups were pooled together, women purchased 
antipsychotics significantly (p <.01) more than men. Further when both groups were pooled 
together the cohort 2011 purchased antipsychotics significantly (p <.001) less than the reference 
cohort 1991. Other cohorts did not differ significantly from the reference cohort.  
 
The interaction of RS placement and gender was non-significant (Table 1). There was statistically 
significant differences between RS and control groups between the different cohorts in the 
purchases of antipsychotics (p<.001). In the RS group none of the cohorts differed significantly 
from the reference cohort 1991 (Table 2). The subjects of the control group in the cohort 2011 
purchased antipsychotics less than those in the reference cohort 1991. Other cohort differences were 
not statistically significant. The five-number summaries for the amounts of purchases of 
antipsychotics are compiled in Appendix B. 
 
4.2.2   ANXIOLYTICS  
The subjects with RS background purchased anxiolytics significantly (p<.001) more than the 
subjects in the control group (Table 1). When both groups were pooled together, women purchased 
anxiolytics significantly (p <.001) more than men. Further when both groups were pooled together 
the cohorts 2006 and 2011 had purchased anxiolytics significantly (p<.001) less than the reference 
cohort 1991. Other cohorts did not differ significantly from the reference cohort. 
 
There were statistically significant (p<.05) gender differences between the RS and control groups in 
the purchases of anxiolytics (Table 1). Also there were statistically significant (p<.01) differences 
between the RS and control groups between the different cohorts in the purchases of anxiolytics. In 
the RS group men and women did not differ significantly in purchasing anxiolytics (Table 2). In the 
control group women bought anxiolytics significantly (p<.001) more than men. In the RS group the 
cohort 2001 purchased anxiolytics significantly (p <.05) less than the reference cohort 1991. Also 
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the cohorts 2006 and 2011 purchased anxiolytics significantly (p<.001) less than the reference 
cohort. In the control group the cohorts 2006 and 2011 purchased anxiolytics significantly (p<.001) 
less than the reference cohort. Other cohort differences were not statistically significant. The five-
number summaries for the amounts of purchases of anxiolytics are compiled in Appendix B. 
 
4.2.3   DRUGS USED FOR SLEEP DISORDERS 
The subjects with RS background purchased drugs used for sleep disorders significantly (p <.001) 
more than the subjects in the control group (Table 1). When both groups were pooled together, 
women purchased drugs used for sleep disorders significantly (p <.01) more than men. Further 
when both groups were pooled together the cohort 2001 (p<.01) and the cohorts 2006 and 2011 
(p<.001) purchased drugs used for sleep disorders significantly less than the reference cohort 1991. 
The cohort 1996 did not differ from the reference cohort. There was no gender differences between 
the RS and control groups. The five-number summaries for the amounts of purchases of drugs used 
for sleep disorders are compiled in Appendix B. 
 
4.2.4   ANTIDEPRESSANTS 
The subjects in the RS group purchased antidepressants significantly (p<.001) more than the 
subjects in the control group (Table 1). When both groups were pooled together, women purchased 
antidepressants significantly (p<.001) more than men. Further when both groups were pooled 
together the cohorts 2001, 2006 and 2011 (p<.001) purchased antidepressants significantly less than 
the reference cohort 1991. The cohort 1996 did not differ from the reference cohort.  
 
The interaction of RS placement and gender was non-significant (Table 1). There were statistically 
significant (p<.001) differences between the RS and control groups between the different cohorts in 
the purchases of antidepressants. In the RS group the cohorts 2006 (p<.05) and 2011 (p<.001) 
purchased antidepressants significantly less than the reference cohort 1991 (Table 2). The cohorts 
1996 and 2001 did nod differ from the reference cohort in the RS group. In the control group those 
in the cohorts 2001, 2006 and 2011 purchased antidepressants significantly (p<.001) less than those 
in the reference cohort 1991. The cohort 1996 did not differ significantly from the reference cohort 
in the control group. The five-number summaries for the amounts of purchases of antidepressants 
are compiled in Appendix B. 
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4.2.5   PSYCHOSTIMULANTS USED FOR ADHD 
The subjects with RS background purchased psychostimulants used for ADHD significantly 
(p<.001) more than the subjects in the control group (Table 1). When both groups were pooled 
together, men purchased psychostimulants used for ADHD significantly (p<.01) more than women. 
Further when both groups were pooled together the cohort 1996 purchased psychostimulants used 
for ADHD significantly (p<.05) less than the reference cohort 1991. The cohort 2011 purchased 
psychostimulants used for ADHD significantly (p<.001) more than the reference cohort. The 
cohorts 2001 and 2006 did not differ from the reference cohort. The interaction of RS placement 
and gender was non-significant. The five-number summaries for the amounts of purchases of 
psychostimulants used for ADHD are compiled in Appendix B. 
 
4.2.6   DRUGS USED IN ALCOHOL DEPENDENCE 
The subjects in the RS group purchased drugs used in alcohol dependence significantly (p<.001) 
more than the subjects in the control group (Table 1). When both groups were pooled together, men 
and women did not differ significantly in purchasing drugs used in alcohol dependence. Further 
when both groups were pooled together the cohorts 2001 (p<.05), 2006 and 2011 (p<.001) 
purchased drugs used in alcohol dependence significantly less than the reference cohort 1991. The 
cohort 1996 did not differ from the reference cohort.  The five-number summaries for the amounts 
of purchases of drugs used in alcohol dependence are compiled in Appendix B. 
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Table 1. Logistic regression models predicting the participation in psychotherapy and the purchases of psychopharmacons with the cohorts, gender, RS placement, the 
interactions between RS placement and gender and RS placement and the cohorts. 
    Psychotherapy   Antipsychotics   Anxiolytics 
    B CI 95% OR RR   B CI 95% OR RR   B CI 95% OR RR 
Cohort 1996 0.39 [-0.20, 1.08] 1.47 1.08  0.00 [-0.44, 0.42] 1.00 1.08  0.09 [-0.27, 0.44] 1.09 1.05 
Reference group: 
1991 
2001 0.00 [-0.65, 0.72] 1.00 1.90  -0.18 [-0.60, 0.27] 0.84 1.02  -0.34 [-0.69, 0.04] 0.71 0.71 
 2006 -0.60 [-1.31, 0.20] 0.55 1.15  -0.12 [-0.53, 0.31] 0.89 1.00  -1.03*** [-1.46, -0.63] 0.36 0.30 
 2011 -1.89***  [-3.61, -1.05] 0.15 0.40  -1.09*** [-1.61, -0.61] 0.34 0.67  -1.54*** [-2.06, -1.07] 0.21 0.13 
Gender men -1.49*** [-2.04, -1.03] 0.23 0.27  -0.34 ** [-0.60, -0.06] 0.72 0.83  -0.46*** [-0.70, -0.23] 0.63 0.81 
Reference group: 
women 
               
RS placement RS group -0.21 [-17.38, 0.87] 0.81 2.10  1.84*** [1.32, 2.43] 6.31 7.40  1.94*** [1.47, 2.40] 6.94 4.30 
Reference group: 
control group 
               
RS placement x Gender 0.29 [-0.64, 1.17] 1.33   0.23 [-0.16, 0.63] 1.26   0.42* [0.04, 0.85] 1.52  
RS placement x Cohort 1996 -0.63 [-17.51, 16.62] 0.53   0.17 [-0.43, 0.80] 1.19   -0.06 [-0.57, 0.47] 0.94  
RS placement x Cohort 2001  1.32* [0.06, 18.33] 3.75   0.41 [-0.17, 1.08] 1.51   -0.19 [-0.75, 0.38] 0.83  
RS placement x Cohort 2006  1.48* [0.10, 18.61] 4.38   0.24 [-0.40, 0.87] 1.27   -0.72* [-1.44, -0.11] 0.48  
RS placement x Cohort 2011  1.94* [0.23, 18.99] 6.96   1.27*** [0.64, 1.91] 3.54   -1.43*** [-2.44, -0.60] 0.24  
Constant   -3.06*** [-3.71, -2.60] 0.05     -2.58*** [-2.99, -2.25] 0.08     -2.07*** [-2.40, -1.78] 0.13   
*** p < .001, ** p < .01, * p < .05.             (continued) 
CI = confidence interval, OR = odds ratio, RR = relative risk.  
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(continued) 
  Drugs used for sleep disorders  Antidepressants  Psychostimulants used for ADHD 
  B CI 95% OR RR  B CI 95% OR RR  B CI 95% OR RR 
Cohort 1996 0.11 [-0.19, 0.42] 1.12 1.03  0.07 [-0.16, 0.30] 1.07 1.01  -1.22* [-3.00, -0.21] 0.30 0.30 
Reference group: 
1991 
2001 -0.55** [-0.91, -0.20] 0.58 0.73  -0.55*** [-0.81, -0.30] 0.58 0.89  0.06 [-0.80, 0.90] 1.06 1.06 
 2006 -1.77*** [-2.27, -1.30] 0.17 0.22  -0.88*** [-1.14, -0.65] 0.41 0.62  0.59 [-0.06, 1.35] 1.80 1.79 
 2011 -5.00*** [-19.2, -3.82] 0.01 0.01  -2.06*** [-2.44, -1.77] 0.13 0.26  1.43*** [0.87, 2.18] 4.16 4.04 
Gender men -0.42** [-0.67, -0.16] 0.66 0.63  -0.70*** [-0.87, -0.55] 0.50 0.60  1.04** [0.30, 2.14] 2.82 3.84 
Reference group: 
women 
               
RS placement RS group 1.40*** [0.90, 1.91] 4.06 4.46  1.59*** [1.17, 2.04] 4.91 3.83  1.88*** [0.81, 2.99] 6.57 8.84 
Reference group: 
control group 
               
RS placement x Gender -0.15 [-0.6, 0.27] 0.86   -0.02 [-0.33, 0.31] 0.98   0.65 [-0.59, 1.84] 1.92  
RS placement x Cohort 1996 -0.16 [-0.71, 0.37] 0.85   -0.11 [-0.57, 0.37] 0.90       
RS placement x Cohort 2001 0.34 [-0.24, 0.91] 1.40   0.74** [0.26, 1.24] 2.09       
RS placement x Cohort 2006 0.20 [-0.57, 0.92] 1.22   0.36 [-0.13, 0.84] 1.43       
RS placement x Cohort 2011 0.97 [-15.80, 15.84] 2.64   0.64* [0.12, 1.22] 1.90       
Constant   -1.94*** [-2.24, -1.68] 0.14     -0.84*** [-1.05, -0.66] 0.43     -6.28*** [-7.56, -5.47] 0.00   
*** p < .001, ** p < .01, * p < .05.             (continued) 
CI = confidence interval, OR = odds ratio, RR = relative risk. 
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(continued) 
  Drugs Used in Alcohol Dependence 
  B CI 95% OR RR 
Cohort 1996 -0.25 [-0.75, 0.29] 0.78 0.79 
Reference group: 
1991 
2001 -0.53* [-1.08, 0.05] 0.59 0.60 
 2006 -2.04*** [-3.28, -1.34] 0.13 0.14 
 2011 -17.78*** [-18.11, -17.37] 0.00 0.00 
Gender men 0.28 [-0.14, 0.82] 1.32 1.32 
Reference group: 
women 
     
RS placement RS group 2.21*** [1.80, 2.67] 9.10 9.08 
Reference group: 
control group 
     
Constant  -4.34*** [-4.99, -3.84] 0.01  
*** p < .001, ** p < .01, * p < .05.      
CI = confidence interval, OR = odds ratio, RR = relative risk. 
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Table 2. Logistic regression models predicting the participation in psychotherapy and the purchases of psychopharmacons with the cohorts or with the cohorts and gender in 
the RS and control groups. 
 
*** p < .001, ** p < .01, * p < .05.                 (continued) 
CI = confidence interval, OR = odds ratio, RR = relative risk.  
 
 
 
    Psychotherapy   
  RS group    Control group   
    B CI 95% OR RR   B CI 95% OR RR 
Cohort 1996 -0.15 [-17.07, 17.13] 0.86 0.86  0.49 [-0.11, 1.20] 1.62 1.60 
Reference group: 
1991 
2001 1.42* [0.32, 18.60] 4.12 3.90  0.14 [-0.50, 0.84] 1.15 1.14 
 2006 1.04 [-0.06, 18.20] 2.83 2.74  -0.39 [-1.16, 0.40] 0.68 0.68 
 2011 0.27 [-1.11, 17.30] 1.31 1.30  -1.62*** [-3.29, -0.75] 0.20 0.20 
Constant   -4.01*** [-21.20, -3.14] 0.02     -3.93*** [-4.60, -3.53] 0.02   
    Antipsychotics 
  RS group    Control group   
    B CI 95% OR RR   B CI 95% OR RR 
Cohort 1996 0.18 [-0.27, 0.64] 1.19 1.13  0.02 [-0.40, 0.46] 1.02 1.02 
Reference group: 
1991 
2001 0.24 [-0.2, 0.73] 1.27 1.17  -0.15 [-0.56, 0.27] 0.86 0.87 
 2006 0.13 [-0.28, 0.61] 1.14 1.09  -0.08 [-0.49, 0.32] 0.93 0.93 
 2011 0.19 [-0.24, 0.63] 1.21 1.14  -1.03*** [-1.48, -0.57] 0.36 0.37 
Constant   -0.81*** [-1.19, -0.49] 0.44     -2.82*** [-3.14, -2.54] 0.06   
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(continued) 
  Anxiolytics 
  RS group    Control group   
    B CI 95% OR RR   B CI 95% OR RR 
Cohort 1996 0.03 [-0.4, 0.45] 1.03 1.02  0.09 [-0.24, 0.45] 1.09 1.08 
Reference group: 
1991 
2001 -0.53* [-1.00, -0.08] 0.59 0.73  -0.34 [-0.68, 0.04] 0.71 0.73 
 2006 -1.76*** [-2.28, -1.28] 0.17 0.28  -1.03*** [-1.44, -0.63] 0.36 0.38 
 2011 -2.97*** [-3.86, -2.34] 0.05 0.09  -1.54*** [-2.02, -1.10] 0.21 0.23 
Gender men -0.04 [-0.38, 0.30] 0.97 1.03  -0.46*** [-0.70, -0.19] 0.63 0.65 
Reference group: 
women 
          
Constant   -0.13 [-0.54, 0.29] 0.88     -2.07*** [-2.41, -1.80] 0.13   
  Antidepressants   
  RS group    Control group   
    B CI 95% OR RR   B CI 95% OR RR 
Cohort 1996 0.00 [-0.44, 0.45] 1.00 1.00  0.11 [-0.12, 0.34] 1.11 1.09 
Reference group: 
1991 
2001 0.24 [-0.19, 0.69] 1.27 1.11  -0.48*** [-0.71, -0.25] 0.62 0.67 
 2006 -0.42* [-0.83, -0.04] 0.66 0.81  -0.78*** [-1.04, -0.53] 0.46 0.52 
 2011 -1.26*** [-1.67, -0.85] 0.28 0.47  -1.92*** [-2.25, -1.60] 0.15 0.18 
Constant   0.20 [-0.10, 0.53] 1.22     -1.34*** [-1.51, -1.17] 0.26   
*** p < .001, ** p < .01, * p < .05. 
CI = confidence Interval, OR = odds ratio, RR = relative risk.  
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5     DISCUSSION 
The aim of this study was to investigate how much former RS adolescents participate in mental 
health rehabilitation services provided by Kela and purchase psychopharmacons compared to their 
peers. The main results of this study were that the persons with RS background do not differ from 
their peers in the participation in psychotherapy, but they purchase 4-9 times more 
psychopharmacons. In addition, women participate in psychotherapy about three times more than 
men and purchase psychopharmacons about 1.5 times more than men, except stimulants used for 
ADHD. Also, the youngest cohorts have participated in psychotherapy and purchased 
psychopharmacons less than the oldest cohort. 
  
5.1    PARTICIPATION IN PSYCHOTHERAPY  
In this study the RS background did not predict participating in psychotherapy more than in the 
control group, despite the results of the previous studies which show that the psychiatric morbidity 
among adolescents placed in RS is high (Lehto-Salo, 2011; Manninen et al., 2010). One partial 
explanation for this discrepancy might be related to earlier legislation. The data of this study project 
was obtained in the end of 2014, in the middle of the essential changes in the legislation making it 
easier to receive the psychotherapy provided by Kela (Act of Changing the Act Concerning the 
Rehabilitation Services and Allowances Provided by Kela 2010/874; 2015/145). Before year 2011, 
Kela´s psychotherapy was provided either as intensive medical therapy or on a discretionary basis. 
From year 2011 the duty to arrange rehabilitative psychotherapy was based on law, and was not 
dependent on the allowances granted by the government anymore. Also, before year 2016, applying 
for psychotherapy as intensive medical therapy required that the applicant received disability or 
care allowance. Therefore, the criteria for receiving psychotherapy before the change in the 
legislation and before this data was acquired were stricter. This is presumably the reason explaining 
why there were only very few that were able to receive psychotherapy before the changes in 
legislation. Further, the same reason may also have faded the differences between those with the RS 
background and their controls. 
 
One reason for not entering the psychotherapy Kela provides can be it´s objectives. The aim of the 
rehabilitative psychotherapy Kela provides is to work as supplementary service for the care 
provided in the public special health care, and specifically to help clients to study and to enter or 
return the workforce (Kela, 2020b). Also, the earlier goal of the psychotherapy as intensive medical 
therapy was to secure the ability to work and function, and only after the change in legislation in 
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2016 it´s aim has been to support also daily functioning and community involvement. It is possible 
that due to the severity of their problems, the persons with RS background may have participated in 
more intensive treatment and shorter psychotherapies arranged in the public special health care, and 
never entered the longer, supplementary psychotherapies provided by Kela.  
 
Further, the complexity of the system may have led to a situation, where many of the persons with 
RS background have not received the psychotherapy they would have needed. Applying for the 
rehabilitative psychotherapy requires three months of care in the public special health care and the 
referral of a psychiatrist (Kela, 2020b). In the referral, the motivation and cabability to discuss 
one´s problems needs to be assessed by psychiatrist, and the patient must also have found a suitable 
therapist to name already in the referral (Heinonen, Kurri, & Melartin, 2016; Kela, 2020b). In 
addition, Kela´s compensation of the psychotherapy does not usually cover all the costs of it and the 
patient has to apply for income support if he can not afford to pay it oneself (Kela, 2019b). 
 
The former research has shown that a part of the those leaving RS have still challenges with agency 
including initiative, determination, and adaptation to the fabric of society (Niiranen et al., under 
review), all of which are needed when seeking Kela´s services. Possible verbal deficits and 
problems to recognize and describe one´s emotions (Lehto-Salo, 2011; Manninen et al., 2013, 
2011), may contribute challenges to receive referral for the psychotherapy Kela provides. Thus, it is 
possible that some of the former RS adolescents may never enter the special health care required 
before Kela´s psychotherapy. For those who enter the system, it may later prove to be too 
challenging for them to observe and discuss their emotions, and to find a suitable therapist. Also the 
low level of education after placement can affect the later income level (Kääriälä & Hiilamo, 2017; 
Talaslampi et al., 2019), forming an obstacle to participate in Kela´s psychotherapy. 
 
There were no cohort differences in the RS and control groups together in the participation in 
psychotherapy, except the youngest cohort 2011 had participated in psychotherapy less than the 
oldest cohort 1991. This was also true for the general population sample only. Among RS 
population only the cohort 2001 had participated in psychotherapy almost four times more than the 
oldest cohort 1991. There were no other cohort differences. This result might partly be explained by 
the timing of the data acquisition, for the cohort 2011 had only a few years before the data was 
obtained. The missing differences between the cohorts may have been levelled out because of the 
earlier, stricter legislation which has caused that only very few have been able to participate in 
psychotherapy provided by Kela. Also, there has been a small increase in the proportion 
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participating in psychotherapy, which started already before the change in legislation in 2011 
(Tuulio-Henriksson, Toikka, Heino, & Laukkala, 2019). Also, the result of an earlier study among 
RS population shows that the proportion of those having problems in RS has increased over years 
(Kitinoja, 2005). These factors may have for one part equalized the differences between the cohorts. 
Since the change in legislation in 2011, there has been a remarkably increase in the proportion 
participating in Kela´s psychotherapy. According to Kela´s statistics, in 2012 in total 35 505 
persons received psychotherapy provided by Kela which is 0.7% of Finland´s whole population 
(Kela, 2020d). In 2019 in total 53 324 persons received Kela´s psychotherapy which is 1.0% of the 
whole population. In older cohorts the amount of compensation may have affected the participation 
in psychotherapy provided by Kela, even though the overall proportions have increased over years. 
Before the year 2016 the compensation for patients over 26 year old was only about 70% of the 
compensation provided for younger patients (Kela, 2015). When the legislation changed, the 
compensation was raised on the same level for everyone.   
 
There were also some gender-related results worth noticing. In general, women had participated in 
psychotherapy about three times more than men and the result was same for those with the RS 
background and their peers. This is in line with Kela´s statistics according to which in 2012 0.3% of 
men and 0.9% of women in general population participated in psychotherapy provided by Kela. An 
earlier study shows that especially among boys living in the RS, the symptoms of depression may 
be under-recognized due the more evident externalizing symptoms, and their self-rated overall 
psychiatric symptoms reach clinical level more frequently than girls´ symptoms (Manninen et al., 
2010). Therefore, it is possible that after the RS placement ends, the mental health problems among 
men remain under-treated even more compared to those among women. 
 
5.2    THE PURCHASES OF PSYCHOPHARMACONS 
Contrary to participation in psychotherapy, the former RS adolescents purchased all of the 
psychopharmacons more than their peers. The purchases of antipsychotics were seven-fold, 
anxiolytics four-fold, drugs used for sleep disorders four-fold, antidepressants almost four-fold, 
psychostimulants used for ADHD almost nine-fold and drugs used in alcohol dependence nine-fold. 
The results are in line with the previous studies indicating that among adolescents placed in RS the 
prevalence of mental health problems is high and these problems tend to continue into adulthood 
(Lehto-Salo, 2011; Manninen et al., 2018, 2014, 2015, 2010). It is possible that from the existing 
treatment options psychopharmacons are more suitable than psychotherapies for the RS population, 
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due to their common problems with cognition, especially with verbal skills (Lehto-Salo, 2011; 
Manninen et al., 2013). 
 
The overall results show that in general, the younger cohorts purchased psychopharmacons less 
than the oldest cohort. Only the purchases of psychostimulants used for ADHD differed from this. 
The youngest cohort 2011 had bought psychostimulants more than the oldest cohort. This may 
indicate the change in the general paradigm, where the diagnosis and treatment of ADHD has 
become more common than before (Vuori, Koski-Pirilä, Martikainen, & Saastamoinen, 2020). 
When investigating the groups separately, only in the purchases of antipsychotics, anxiolytics and 
antidepressants were differences between the groups over time. The differences in the purchases of 
anxiolytics between the groups were minor and were in line with the overall results. Also the 
purchases of antidepressants were mainly in line with the overall results, but among those with RS 
background only two of the youngest cohorts had bought antidepressants less than the oldest cohort. 
In the purchases of antipsychotics, among those with RS background none of the cohorts differed 
from the oldest cohort 1991. Among controls only the youngest cohort 2011 had bought 
antipsychotics less than the oldest cohort 1991. The missing differences between the cohorts in the 
purchases of antidepressants and antipsychotics may be partly explained with the increases in the 
purchases of them over the years (Finnish Medicines Agency Fimea & Kela, 2019). It may be, that 
each of the younger cohorts have purchased antidepressants and antipsychotics slightly more than 
the older cohorts diminishing the differences between the cohorts. 
 
There were some gender differences in the purchases of psychopharmacons. In general women had 
purchased psychopharmacons more than men, except the psychostimulants used for ADHD and 
drugs used in alcohol dependence. Men had purchased psychostimulants almost four times more 
than women, which is in line with the results that the incidence of ADHD and the use of 
psychostimulants in it´s treatment is higher in men (Vuori et al., 2020). There were no gender 
differences in the purchases of drugs used in alcohol dependence. The earlier studies have shown 
that the alcohol consumption increased in Finland between 1960´s and 2000´s and has decreased in 
the 2010’s (Jääskeläinen & Virtanen, 2020; Mäkelä, Mustonen, & Huhtanen, 2010). Although the 
use of alcohol among women has increased, men use it still more (Mäkelä et al., 2010). The missing 
gender differences may result from the small overall proportion in the purchases of drugs used in 
alcohol dependence. Even though there has been increase in the overall consumption of alcohol, the 
problematic abuse treated with medication may still remain marginal. Only in the purchases of 
anxiolytics there were gender differences between those with the RS background and their peers. In 
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the general population women used anxiolytics more but among the former RS adolescents there 
were no gender differences. Generally, on the strength of these results it seems that the psychiatric 
morbidity is better recognized among women with RS background. Only the anxiolytics make an 
exception in these results indicating that the anxiety of the men with RS background may be 
recognized better than other mental health problems. On the other hand, these results do not 
necessarily indicate, that all of the anxiolytics end in the use they were prescribed. As earlier studies 
show, substance abuse among those placed in RS is common, and after placement the risk for drug 
offence is higher than in general population (Lehto-Salo, 2011; Manninen et al., 2015, 2017). Based 
on these results it may be hypothesized that at least part of the anxiolytics may end in substance 
abuse or illegal drug sales instead of actual anxiety disorder. 
 
5.3    LIMITATIONS AND STRENGTHS 
There are some limitations in the current study. Because the psychotherapies provided by Kela are 
so strongly aimed at employment, it would have been reasonable to obtain and control also 
unemployment benefits in the analyses, as it may have been an important predictor especially for 
the participation in psychotherapy. Also, because there are no detailed statistics on the participation 
in the shorter psychotherapies provided in the special health care or in other mental health services, 
it is impossible to say reliably how much former RS adolescents participate in psychotherapy in 
total. The strength of this study was, that all of those placed in RS were included in the analyses, 
with no dropouts and each of them had from four to five matched controls ensuring the reliability of 
the group comparisons. Also the data from the Finnish registries can be considered reliable, 
although there might be some mistakes in the data entry. 
 
5.4    IMPLICATIONS FOR FUTURE RESEARCH AND PRACTICE 
The results of this study give important indications on how former RS adolescents participate in 
psychotherapies and purchase psychopharmacons, for there has been no earlier research on the 
topic. Taken together, these results show that even though the psychiatric morbidity among the 
persons with RS background is high, they do not participate in the Kela´s psychotherapy services 
more than their peers. On the other hand, those with RS background purchase psychopharmacons 
remarkably more compared to their peers. In the following studies it would be important to research 
also the participation in the psyciatric special health care services, as detailed as there are statistics 
on them. The legislation of the rehabilitation services provided by Kela has changed a lot after the 
data for this study was obtained. Therefore, in the following studies it would be important to 
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acquire up-to-date statistics including also the statistics on unemployment benefits and the use of 
psychiatric special health care.  
 
In the future, it is important to pay more attention on how well mental health problems are assessed 
and treated both in RS and during aftercare, and do the services offered meet the needs of RS 
adolescents. The aim of the service system should be that mental health symptoms would be 
assessed on a routine basis, and if they were found, there should be mental health care available, 
and it should be offered actively. Instead of the complex system based on the assessment and 
treatment in the special health care, assessment and shorter psychotherapies could be offered 
already in the primary care (Clark, 2018). This could help also those with more serious mental 
health problems to access the services. According to the Quality Recommendation for Child 
Welfare, well-timed cooperation between child welfare and mental health services must be ensured 
(Malja, Puustinen-Korhonen, Petrelius, & Eriksson, 2019). For those adolescents placed in RS, this 
means that mental health services should be available already in the RS. After leaving care the 
responsibility of aftercare should be to ensure that all of the adolescents leaving care would be able 
to access mental health services if needed. In the beginning of 2020 the age limit of aftercare 
changed from 21 years to 25 years (Act of Changing the Child Welfare Act 2019/542). This should 
make it easier to follow the well-being of those leaving care and direct and help them into services 
they need. It is also important to note, that not all of those with RS background are capable of 
discussing their problems in a traditional psychotherapy. There should be more interventions 
available, that would better serve those, who have verbal deficits or problems to recognize their 
own feelings. Taken together, there is an evident need for mental health services which would serve 
the needs of those with RS background better than before. There should be wider range of mental 
health services available, and it should be made as easy as possible to access them. 
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APPENDICES 
 
 
Appendix A. The ATC-codes for the subgroups of psychopharmacons. 
Subgroup ATC-codes 
Antiepileptics N03 
Clonazepam  N03AE01 
Antipsychotics N05A; N05AN not inluded 
Lithium  N05AN 
Anxiolytics N05B, N05CD N05CD02 N05CD05 N05CD07 
N05CD08; N05BB01 and N05BE01 not included 
Buspirone  N05BE01 
Drugs used for sleep disorders N05CF01 N05CF02 N05CF03 N05CH N05CH01 
N05CM N05CM09 N05CM18 
Antidepressants N06A, N06CA01, N06CA01 N06CA03 
Psychostimulants used for ADHD N06BA04, N06BA09 
Drugs used in nicotine dependence N07BA, N07BA01, N07BA03 
Drugs used in alcohol dependence N07BB01, N07BB04 
Drugs used in opioid dependence N07BC02, N07BC51 
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Appendix B. The amounts and percentages of subjects participating in psychotherapy and purchasing psychopharmacons, and five-number summaries for the length of 
psychotherapy in days and the amounts of purchases of psychopharmacons. 
 Psychotherapy 
 RS group 
 Men    Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 1 (0.79) 728 728 728 728 728  2 (4.65) 1093 1093 1229 1365 1365  3 (1.78) 728 728 1093 1365 1365 
1996 1 (0.75) 570 570 570 570 570  2 (3.23) 364 364 364.5 365 365  3 (1.53) 364 364 365 570 570 
2001 3 (2.24) 728 728 728 1820 1820  11 (16.18) 211 364 1092 1093 1457  14 (6.93) 211 365 910 1093 1820 
2006 6 (3.92) 364 365 636.5 730 1458  6 (6.38) 365 728 910.5 1092 1457  12 (4.86) 364 454.5 729 1092 1458 
2011 3 (2.00) 729 729 1787 2526 2526  3 (2.73) 365 365 1093 1093 1093  6 (2.31) 365 729 1093 1787 2526 
Total 14 (2.01) 364 570 728.5 1458 2526  24 (6.37) 211 365 1092 1093 1457  38 (3.54) 211 365 729 1093 2526 
 Control group 
 Men    Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 6 (0.97) 728 1072 1092.5 1093 1184  10 (4.67) 364 365 909.5 1093 1093  16 (1.92) 364 728 1091 1093 1184 
1996 12 (1.81) 190 364.5 910 1274.5 1821  18 (5.84) 364 365 759.5 1093 1819  30 (3.09) 190 365 759.5 1093 1821 
2001 5 (0.76) 364 364 365 729 1093  17 (5.03) 364 728 1091 1093 1474  22 (2.20) 364 365 729 1093 1474 
2006 3 (0.40) 
145
8 
1458 1822 3278 3278  13 (2.80) 365 728 1093 1456 2154  16 (1.31) 365 789 1093.5 1639 3278 
2011 3 (0.40) 333 333 728 853 853  2 (0.37) 364 364 728 1092 1092  5 (0.39) 333 364 728 853 1092 
Total 29 (0.84) 190 365 1072 1093 3278   60 (3.21) 364 728 1090.5 1093 2154   89 (1.68) 190 365 1090 1093 3278 
n = number of subjects participating in psychotherapy, % = percentage of subjects in each cohort and group participating in psychotherapy.     (continued) 
Min = minimum length of psychotherapy in days, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum length of psychotherapy in days. 
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(continued) 
 Antipsychotics 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 38 (30.16) 1 1 3 15 308  14 (32.56) 1 2 17.5 63 205  52 (30.77) 1 2 4 21 308 
1996 37 (27.61) 1 2 5 11 59  31 (50.00) 1 2 4 11 136  68 (34.69) 1 2 4 11 136 
2001 44 (32.84) 1 2 5 13.5 95  29 (42.65) 1 3 7 16 62  73 (36.14) 1 2 6 14 95 
2006 52 (33.99) 1 2 4 14 77  31 (32.98) 1 2 5 13 81  83 (33.6) 1 2 4 13 81 
2011 61 (40.67) 1 4 12 20 49  30 (27.27) 1 2 3 5 19  91 (35.00) 1 3 8 17 49 
Total 232 (33.29) 1 2 6 17 308  135 (35.81) 1 2 4 13 205  367 (34.17) 1 2 5 16 308 
 Control group 
 Men    Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 30 (4.85) 1 2 4 21 114  17 (7.94) 1 1 2 18 45  47 (5.65) 1 1 4 21 114 
1996 36 (5.42) 1 2 11 32 108  20 (6.49) 1 3 7 20 98  56 (5.76) 1 2.5 8 27.5 108 
2001 31 (4.68) 1 1 3 13 52  18 (5.33) 1 2 8 24 33  49 (4.90) 1 1 3 16 52 
2006 34 (4.52) 1 1 3 10 54  30 (6.47) 1 1 2 5 42  64 (5.26) 1 1 2.5 7.5 54 
2011 12 (1.61) 1 1 2 14 35  15 (2.75) 1 2 3 10 21  27 (2.09) 1 1 3 13 35 
Total 143 (4.15) 1 1 4 19 114   100 (5.35) 1 1 3 13.5 98   243 (4.57) 1 1 4 16 114 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.    (continued) 
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
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(continued) 
 Anxiolytics 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 61 (48.41) 1 3 11 41 265  17 (39.53) 1 1 4 29 151  78 (46.15) 1 2 8 40 265 
1996 62 (46.27) 1 4 18.5 78 233  30 (48.39) 1 4 15 58 184  92 (46.94) 1 4 17.5 71.5 233 
2001 41 (30.60) 1 4 10 36 177  27 (39.71) 1 2 11 29 184  68 (33.66) 1 3 10.5 32.5 184 
2006 19 (12.42) 1 1 3 9 49  13 (13.83) 1 1 1 3 57  32 (12.96) 1 1 2 6 57 
2011 8 (5.33) 1 1 1 2.5 15  3 (2.73) 1 1 1 2 2  11 (4.23) 1 1 1 2 15 
Total 191 (27.40) 1 2 10 41 265  90 (23.87) 1 2 6.5 29 184  281 (26.16) 1 2 9 38 265 
 Control group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 43 (6.96) 1 1 5 30 216  27 (12.62) 1 1 3 6 14  70 (8.41) 1 2 8 40 265 
1996 55 (8.28) 1 1 3 22 94  36 (11.69) 1 1 3 9.5 51  91 (9.36) 1 4 17.5 71.5 233 
2001 36 (5.44) 1 1 2 9.5 45  28 (8.28) 1 1 2.5 10 140  64 (6.40) 1 3 10.5 32.5 184 
2006 21 (2.79) 1 1 1 2 14  20 (4.31) 1 1 1 3.5 32  41 (3.37) 1 1 2 6 57 
2011 14 (1.87) 1 1 1 1 2  13 (2.39) 1 1 1 2 5  27 (2.09) 1 1 1 2 15 
Total 169 (4.91) 1 1 2 10 216   124 (6.63) 1 1 2 5.5 140   293 (5.51) 1 2 9 38 265 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.    (continued) 
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
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 Drugs used for sleep disorders 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 34 (26.98) 1 1 2 8 36  13 (30.23) 1 2 6 11 73  47 (27.81) 1 1 3 10 73 
1996 28 (20.90) 1 1 2 8 34  26 (41.94) 1 1 3 4 50  54 (27.55) 1 1 2.5 5 50 
2001 28 (20.90) 1 1 2.5 10 40  22 (32.35) 1 1 4 12 40  50 (24.75) 1 1 3 10 40 
2006 11 (7.19) 1 1 1 2 4  9 (9.57) 1 1 2 7 10  20 (8.10) 1 1 1 3.5 10 
2011 1 (0.67) 1 1 1 1 1  1 (0.91) 1 1 1 1 1  2 (0.77) 1 1 1 1 1 
Total 102 (14.63) 1 1 2 7 40  71 (18.83) 1 1 3 8 73  173 (16.11) 1 1 2 8 73 
 Control group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 54 (8.74) 1 1 1 4 110  26 (12.15) 1 1 2 4 12  80 (9.62) 1 1 1.5 4 110 
1996 66 (9.94) 1 1 2 5 36  40 (12.99) 1 1 1.5 4.5 38  106 (10.91) 1 1 2 5 38 
2001 33 (4.98) 1 1 1 2 11  27 (7.99) 1 1 1 3 33  60 (6.00) 1 1 1 2.5 33 
2006 9 (1.20) 1 1 1 2 5  14 (3.02) 1 1 2 3 21  23 (1.89) 1 1 2 3 21 
2011 1 (0.13) 1 1 1 1 1  0 (0.00) . . . . .  1 (0.08) 1 1 1 1 1 
Total 163 (4.73) 1 1 1 4 110   107 (5.72) 1 1 2 4 38   270 (5.08) 1 1 1 4 110 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.    (continued) 
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
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 Antidepressants 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 68 (53.97) 1 2 4 11 48  25 (58.14) 1 4 10 26 55  93 (55.03) 1 2 4 13 55 
1996 58 (43.28) 1 2 5.5 14 46  50 (80.65) 1 3 8.5 15 82  108 (55.1) 1 3 7.5 15 82 
2001 70 (52.24) 1 2 5 11 49  53 (77.94) 1 5 10 21 71  123 (60.89) 1 3 6 16 71 
2006 60 (39.22) 1 2 2 9 28  50 (53.19) 1 3 5 10 60  110 (44.53) 1 2 4 9 60 
2011 36 (24.00) 1 2 4 7 45  31 (28.18) 1 2 4 9 22  67 (25.77) 1 2 4 8 45 
Total 292 (41.89) 1 2 4 10 49  209 (55.44) 1 3 7 15 82  501 (46.65) 1 2 5 12 82 
 Control group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 108 (17.48) 1 2 5 12.5 72  65 (30.37) 1 4 6 20 56  173 (20.79) 1 2 6 15 72 
1996 122 (18.37) 1 2 6 13 249  98 (31.82) 1 2 9 22 107  220 (22.63) 1 2 7 16 249 
2001 77 (11.63) 1 2 4 7 57  63 (18.64) 1 2 7 18 60  140 (14) 1 2 5 12.5 60 
2006 55 (7.3) 1 1 2 7 21  76 (16.38) 1 2 3 10.5 38  131 (10.76) 1 2 3 8 38 
2011 23 (3.08) 1 1 3 9 20  25 (4.59) 1 2 3 7 15  48 (3.72) 1 1 3 7 20 
Total 385 (11.18) 1 2 5 10 249   327 (17.5) 1 2 6 16 107   712 (13.4) 1 2 5 13 249 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.    (continued) 
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
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 Psychostimulants used for ADHD 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 8 (6.35) 3 5.5 8.5 31 121  0 (0) . . . . .  8 (4.73) 3 5.5 8.5 31 121 
1996 1 (0.75) 13 13 13 13 13  1 (1.61) 2 2 2 2 2  2 (1.02) 2 2 7.5 13 13 
2001 10 (7.46) 1 2 3.5 6 13  0 (0) . . . . .  10 (4.95) 1 2 3.5 6 13 
2006 15 (9.80) 1 1 7 12 49  2 (2.13) 2 2 2.5 3 3  17 (6.88) 1 2 5 9 49 
2011 34 (22.67) 1 2 6 18 56  6 (5.45) 1 3 13 17 18  40 (15.38) 1 2 7 18 56 
Total 68 (9.76) 1 2 6 15 121  9 (2.39) 1 2 3 15 18  77 (7.17) 1 2 6 15 121 
 Control group 
 Men    Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 3 (0.49) 1 1 3 17 17  1 (0.47) 23 23 23 23 23  4 (0.48) 1 2 10 20 23 
1996 2 (0.30) 6 6 14 22 22  0 (0.00) . . . . .  2 (0.21) 6 6 14 22 22 
2001 3 (0.45) 3 3 5 12 12  1 (0.30) 7 7 7 7 7  4 (0.40) 3 4 6 9.5 12 
2006 7 (0.93) 1 2 11 19 26  3 (0.65) 1 1 4 8 8  10 (0.82) 1 2 7 12 26 
2011 16 (2.14) 1 2 8 40.5 67  2 (0.37) 6 6 9.5 13 13  18 (1.39) 1 2 8 37 67 
Total 31 (0.90) 1 2 7 20 67   7 (0.37) 1 4 7 13 23   38 (0.72) 1 2 7 19 67 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.    (continued) 
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
 
 
  
  37 
(continued) 
 Drugs used in alcohol dependence 
 RS group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 17 (13.49) 1 1 1 2 27  4 (9.30) 1 1.5 2 8 14  21 (12.43) 1 1 1 2 27 
1996 11 (8.21) 1 1 1 2 2  7 (11.29) 1 1 1 2 3  18 (9.18) 1 1 1 2 3 
2001 11 (8.21) 1 1 2 2 5  6 (8.82) 1 1 1 2 2  17 (8.42) 1 1 1 2 5 
2006 4 (2.61) 1 1 1 2 3  2 (2.13) 1 1 1 1 1  6 (2.43) 1 1 1 1 3 
2011 0 (0.00) . . . . .  0 (0.00) . . . . .  0 (0.00) . . . . . 
Total 43 (6.17) 1 1 1 2 27  19 (5.04) 1 1 1 2 14  62 (5.77) 1 1 1 2 27 
 Control group 
 Men       Women  Total 
 n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max  n (%) Min Q1 Median Q3 Max 
Cohort                     
1991 11 (1.78) 1 1 1 4 4  3 (1.40) 1 1 1 1 1  14 (1.68) 1 1 1 3 4 
1996 13 (1.96) 1 1 1 2 5  1 (0.32) 5 5 5 5 5  14 (1.44) 1 1 1 2 5 
2001 6 (0.91) 1 1 2 2 3  2 (0.59) 1 1 1 1 1  8 (0.80) 1 1 1.5 2 3 
2006 1 (0.13) 1 1 1 1 1  0 (0.00) . . . . .  1 (0.08) 1 1 1 1 1 
2011 0 (0.00) . . . . .  0 (0.00) . . . . .  0 (0.00) . . . . . 
Total 31 (0.90) 1 1 1 2 5   6 (0.32) 1 1 1 1 5   37 (0.70) 1 1 1 2 5 
n = number of subjects purchasing psycohparhmacons, % = percentage of subjects in each cohort and group purchasing psychopharmacons.     
Min = minimum amount of puchases of psychopharmacons, Q1 = 1st quartile, Q3 = 3rd quartile, max = maximum amount of the puchases of psychopharmacons. 
 
